Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria

Objectives This is a protocol for Cochrane Review (diagnostic). The objectives are as follows: To assess the diagnostic accuracy of near‐patient tests G6PD deficiency in people undergoing treatment or prophylaxis with primaquine tafenoquine malaria; at risk susceptible to malaria. Secondary investigate sources heterogeneity, namely following. Age: adults versus children Sex: male female Reported prevalence (high low) Malaria endemicity (endemic non‐endemic) Geographic location (continent residence; that is, Africa, Asia, other continent) Reference standard used (adjusted median, median G6PD, laboratory standard) Type blood (venous capillary) compare each type test.